These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34176089)

  • 21. Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma.
    Tran TB; Qadan M; Dua MM; Norton JA; Poultsides GA; Visser BC
    Surgery; 2015 Aug; 158(2):486-93. PubMed ID: 26013988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Original study: The rescue staging for pancreatic ductal adenocarcinoma with inadequate examined lymph nodes.
    Fu N; Wang W; Cheng D; Wang J; Xu Z; Deng X; Peng C; Chen H; Shen B
    Pancreatology; 2021 Jun; 21(4):724-730. PubMed ID: 33642141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical value of lymph node dissection of No. 14cd during pancreaticoduodenectomy in patients with pancreatic head carcinoma].
    Wu PF; Zhang K; Tian L; Yin J; Wei JS; Xi CH; Chen JM; Guo F; Lu ZP; Miao Y; Jiang KR
    Zhonghua Wai Ke Za Zhi; 2023 Jul; 61(7):582-589. PubMed ID: 37402687
    [No Abstract]   [Full Text] [Related]  

  • 24. Are Lymph Node Metastases Associated With Survival in Black Patients With Pancreatic Cancer?
    Fang HA; Irfan A; Vickers SM; Gbolahan O; Williams GR; Outlaw D; Wang TN; Dudeja V; Rose JB; Reddy S
    J Surg Res; 2023 Apr; 284():143-150. PubMed ID: 36571869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?
    Konstantinidis IT; Deshpande V; Zheng H; Wargo JA; Fernandez-del Castillo C; Thayer SP; Androutsopoulos V; Lauwers GY; Warshaw AL; Ferrone CR
    J Gastrointest Surg; 2010 Feb; 14(2):261-7. PubMed ID: 19937477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas.
    Conrad C; Kutlu OC; Dasari A; Chan JA; Vauthey JN; Adams DB; Kim M; Fleming JB; Katz MH; Lee JE
    J Gastrointest Surg; 2016 Dec; 20(12):1966-1974. PubMed ID: 27714644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Proposal for a Revised N Classification for TNM Staging.
    Basturk O; Saka B; Balci S; Postlewait LM; Knight J; Goodman M; Kooby D; Sarmiento JM; El-Rayes B; Choi H; Bagci P; Krasinskas A; Quigley B; Reid MD; Akkas G; Maithel SK; Adsay V
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1187-95. PubMed ID: 26362048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathomorphological features of metastatic lymph nodes as predictors of postoperative prognosis in pancreatic cancer.
    Hoshikawa M; Ogata S; Nishikawa M; Kimura A; Einama T; Noro T; Aosasa S; Hase K; Tsujimoto H; Ueno H; Yamamoto J
    Medicine (Baltimore); 2019 Feb; 98(5):e14369. PubMed ID: 30702628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
    Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
    Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discordance Between Conventional and Detailed Lymph Node Analysis in Resected, Node-negative Pancreatic or Ampullary Adenocarcinomas and Association With Adverse Survival Outcomes: A Single-institution Analysis.
    Elshami M; Ammoun AK; Mneimneh WS; Stitzel HJ; Hue JJ; Wu VS; Kyasaram RK; Shanahan J; Musonza T; Ammori JB; Hardacre JM; Winter JM; ElHag M; Ocuin LM
    Ann Surg; 2023 Dec; 278(6):e1204-e1209. PubMed ID: 37051926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
    Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
    Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment.
    You MS; Lee SH; Choi YH; Shin BS; Paik WH; Ryu JK; Kim YT; Jang DK; Lee JK; Kwon W; Jang JY; Kim SW
    BMC Cancer; 2019 Oct; 19(1):952. PubMed ID: 31615457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic assessment of different lymph node staging methods for pancreatic cancer with R0 resection: pN staging, lymph node ratio, log odds of positive lymph nodes.
    La Torre M; Nigri G; Petrucciani N; Cavallini M; Aurello P; Cosenza G; Balducci G; Ziparo V; Ramacciato G
    Pancreatology; 2014; 14(4):289-94. PubMed ID: 25062879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of morphological features in lymph node metastasis between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomas.
    Takahashi D; Kojima M; Morisue R; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Gotohda N; Ikeda M; Ochiai A
    Pancreatology; 2020 Jul; 20(5):936-943. PubMed ID: 32553561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical impact of the lymph node ratio as a prognostic factor after resection of pancreatic cancer.
    Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    Anticancer Res; 2014 May; 34(5):2389-94. PubMed ID: 24778048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An interactive Bayesian model for prediction of lymph node ratio and survival in pancreatic cancer patients.
    Smith BJ; Mezhir JJ
    J Am Med Inform Assoc; 2014 Oct; 21(e2):e203-11. PubMed ID: 24444460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of nodal statuses in patients with pancreatic ductal adenocarcinoma.
    Fukuda Y; Asaoka T; Maeda S; Hama N; Miyamoto A; Mori M; Doki Y; Nakamori S
    Pancreatology; 2017; 17(2):279-284. PubMed ID: 28122676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Berger AC; Watson JC; Ross EA; Hoffman JP
    Am Surg; 2004 Mar; 70(3):235-40; discussion 240. PubMed ID: 15055847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma.
    Spolverato G; Ejaz A; Kim Y; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Votanopoulos K; Acher AW; Jin LX; Hawkins WG; Schmidt C; Kooby DA; Worhunsky D; Saunders N; Cho CS; Levine EA; Maithel SK; Pawlik TM
    Ann Surg; 2015 Dec; 262(6):991-8. PubMed ID: 25563867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
    Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
    Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.